GLP-1 medication brands
Reference information on major GLP-1 brand medications and how they compare to compounded alternatives.
Ozempic: what it is, how it works, and alternatives
Ozempic is the brand name for injectable semaglutide manufactured by Novo Nordisk, FDA-approved for type 2 diabetes treatment. While frequently prescribed off-label for weight management, Ozempic is not specifically approved for that indication.
Wegovy: semaglutide approved for weight management
Wegovy is the brand name for higher-dose injectable semaglutide, FDA-approved specifically for chronic weight management in adults with obesity or overweight with comorbidities.
Zepbound: tirzepatide approved for weight management
Zepbound is the brand name for injectable tirzepatide manufactured by Eli Lilly, FDA-approved for chronic weight management. It acts on two receptors: GIP and GLP-1.
Mounjaro: tirzepatide for type 2 diabetes
Mounjaro is the brand name for injectable tirzepatide manufactured by Eli Lilly, approved for type 2 diabetes treatment. Like Zepbound, it acts on both GIP and GLP-1 receptors.
Rybelsus: oral semaglutide
Rybelsus is the brand name for oral semaglutide manufactured by Novo Nordisk, approved for type 2 diabetes treatment. It is the first oral formulation of a GLP-1 receptor agonist.
Ready to start?
Online evaluation, review by a licensed provider. If you qualify, plans from $99.
Start evaluation